Cerament G is the first injectable of its kind and can be delivered in a single procedure to support bone remodeling and protect bone healing, according to a May 19 news release. It is designed to prevent bone infection that can arise from fractures, orthopedic implants and foot ulcers.
“This is a significant recognition for the power and promise of our technology, as we are the first-to-market in the U.S. with this breakthrough combination device,” Bonesupport CEO Emil Billbaeck said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
